Abstract:Caenorhabditis elegans (C. elegans) is gaining recognition and importance as an organismic model for toxicity testing in line with the 3Rs principle (replace, reduce, refine). In this study, we explored the use of C. elegans to examine the toxicities of alkylating sulphur mustard analogues, specifically the monofunctional agent 2-chloroethyl-ethyl sulphide (CEES) and the bifunctional, crosslinking agent mechlorethamine (HN2). We exposed wild-type worms at different life cycle stages (from larvae L1 to adulthood day 10) to CEES or HN2 and scored their viability 24 h later. The susceptibility of C. elegans to CEES and HN2 paralleled that of human cells, with HN2 exhibiting higher toxicity than CEES, reflected in LC50 values in the high µM to low mM range. Importantly, the effects were dependent on the worms' developmental stage as well as organismic age: the highest susceptibility was observed in L1, whereas the lowest was observed in L4 worms. In adult worms, susceptibility to alkylating agents increased with advanced age, especially to HN2. To examine reproductive effects, L4 worms were exposed to CEES and HN2, and both the offspring and the percentage of unhatched eggs were assessed. Moreover, germline apoptosis was assessed by using ced-1p::GFP (MD701) worms. In contrast to concentrations that elicited low toxicities to L4 worms, CEES and HN2 were highly toxic to germline cells, manifesting as increased germline apoptosis as well as reduced offspring number and percentage of eggs hatched. Again, HN2 exhibited stronger effects than CEES. Compound specificity was also evident in toxicities to dopaminergic neurons-HN2 exposure affected expression of dopamine transporter DAT-1 (strain BY200) at lower concentrations than CEES, suggesting a higher neurotoxic effect. Mechanistically, nicotinamide adenine dinucleotide (NAD+) has been linked to mustard agent toxicities. Therefore, the NAD+-dependent system was investigated in the response to CEES and HN2 treatment. Overall NAD+ levels in worm extracts were revealed to be largely resistant to mustard exposure except for high concentrations, which lowered the NAD+ levels in L4 worms 24 h post-treatment. Interestingly, however, mutant worms lacking components of NAD+-dependent pathways involved in genome maintenance, namely pme-2, parg-2, and sirt-2.1 showed a higher and compound-specific susceptibility, indicating an active role of NAD+ in genotoxic stress response. In conclusion, the present results demonstrate that C. elegans represents an attractive model to study the toxicology of alkylating agents, which supports its use in mechanistic as well as intervention studies with major strength in the possibility to analyze toxicities at different life cycle stages.

Caenorhabditis elegans Neurotoxicity Testing: Novel Applications in the Adverse Outcome Pathway Framework

Modeling neurodegeneration in Caenorhabditis elegans

How neurobehavior and brain development in alternative whole-organism models can contribute to prediction of developmental neurotoxicity

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Caenorhabditis elegans as a powerful alternative model organism to promote research in genetic toxicology and biomedicine

Caenorhabditis elegans: a model organism in the toxicity assessment of environmental pollutants

Caenorhabditis Elegans As a Complete Model Organism for Biosafety Assessments of Nanoparticles.

Stem cell-based approaches for developmental neurotoxicity testing

Cyanobacterial Xenobiotics As Evaluated by a Caenorhabditis Elegans Neurotoxicity Screening Test.

Caenorhabditis elegans as a complete model organism for biosafety assessments of nanoparticles

Advances in the Toxicity Evaluation of Environmental Exposure based on Caenorhabditis Elegans at Different Developmental Stages

A high-throughput microplate toxicity screening platform based on Caenorhabditis elegans

Life-Cycle-Dependent Toxicities of Mono- and Bifunctional Alkylating Agents in the 3R-Compliant Model Organism C. elegans

Caenorhabditis Elegans As a Model System for Target Identification and Drug Screening Against Neurodegenerative Diseases.

Caenorhabditis elegans as a Model for Evaluating the Toxicology of Inorganic Nanoparticles

Zebrafish and nematodes as whole organism models to measure developmental neurotoxicity

Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions

Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing

Effect of altered production and storage of dopamine on development and behavior in C. elegans

A Brief Review on Caenorhabditis elegans Role in Modelling Neurodegenerative Disease

Preliminary Acute Toxicity Assessment of Pharmaceutical Compounds by Caenorhabditis Elegans